興科蓉醫藥：2025中期報告.pdf

1、2025INTERIM REPORT 中期報告Contents目錄2Corporate Information公司資料4Financial Highlights財務摘要6Corporate Profile公司簡介7Management Discussion and Analysis管理層討論及分析23Other Information其他資料32Independent Review Report獨立審閱報告34Interim Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income中期簡明

2、綜合損益及其他全面收益表35Interim Condensed Consolidated Statement of Financial Position中期簡明綜合財務狀況表37Interim Condensed Consolidated Statement of Changes in Equity中期簡明綜合權益變動表38Interim Condensed Consolidated Statement of Cash Flows中期簡明綜合現金流量表40Notes to Interim Condensed Financial Information中期簡明財務資料附註66Definition

3、s釋義Corporate Information公司資料2Sinco Pharmaceuticals Holdings Limited Interim Report 2025BOARD OF DIRECTORSExecutive DirectorsMr.Huang Xiangbin(Chairman)Mr.Huang Zhijian(Vice Chairman)Mr.Lei ShifengNon-executive DirectorMs.Jing HuanIndependent Non-executive DirectorsMr.Bai Zhizhong(Lead Independent No

4、n-executive Director)(appointed as Lead Independent Non-executive Director on 27 August 2025)Mr.Lau Ying KitMr.Liu WenfangMr.Wang QingAUDIT COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Liu WenfangMr.Wang QingMr.Bai ZhizhongREMUNERATION COMMITTEEMr.Wang Qing(Chairman)Mr.Liu WenfangMr.Bai ZhizhongMr.Lei Shife

5、ngNOMINATION COMMITTEEMr.Huang Xiangbin(Chairman)Mr.Liu WenfangMr.Lau Ying KitMs.Jing Huan(appointed on 27 August 2025)Mr.Bai Zhizhong(appointed on 27 August 2025)INTERNAL CONTROL AND CORPORATE GOVERNANCE COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Wang QingMr.Liu WenfangMr.Bai ZhizhongMr.Lei ShifengAUTHOR

6、ISED REPRESENTATIVESMr.Huang XiangbinMs.Peng YunluCOMPANY SECRETARYMs.Peng Yunlu董事會執行董事黃祥彬先生（主席）黃智健先生（副主席）雷世鋒先生非執行董事敬歡女士獨立非執行董事白志中先生（首席獨立非執行董事）（於2025年8月27日獲委任為首席獨立非執行董事）劉英傑先生劉文芳先生汪晴先生審核委員會劉英傑先生（主席）劉文芳先生汪晴先生白志中先生薪酬委員會汪晴先生（主席）劉文芳先生白志中先生雷世鋒先生提名委員會黃祥彬先生（主席）劉文芳先生劉英傑先生敬歡女士（於2025年8月27日獲委任）白志中先生（於2025年8月27日